Transcripta Bio raises $24.0M (United States, Jul 2026)

Transcripta Bio Raises $24M for AI Drug Discovery - AllSci

Transcripta Bio is an AI-driven drug discovery startup focused on developing small molecule therapeutics to modulate gene expression disease signatures. The company aims to advance IND-enabling studies and clinical preparation for neurological diseases, including autism spectrum disorder and muscular dystrophy. Their innovative approach leverages robotic platforms and AI models to enhance drug discovery success rates.

Transcripta Bio Raises $24M for AI Drug Discovery  AllSci